April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Clinical Experience with Sulcus-Implanted Baerveldt Glaucoma Tube Shunts Fully Concealed Behind the Iris in Pseudophakic Eyes
Author Affiliations & Notes
  • Adam J. Weiner
    University of Michigan, Ann-Arbor, Michigan
  • Omar Faridi
    Beaumont Eye Institute,
    William Beaumont Hospital, Royal Oak, Michigan
  • Mamtha Balasubramaniam
    Beaumont Research Institute,
    William Beaumont Hospital, Royal Oak, Michigan
  • Asher Weiner
    Beaumont Eye Institute,
    William Beaumont Hospital, Royal Oak, Michigan
    Ophthalmic Consultants of the Capital Region, Troy, New York
  • Footnotes
    Commercial Relationships  Adam J. Weiner, None; Omar Faridi, None; Mamtha Balasubramaniam, None; Asher Weiner, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2640. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Adam J. Weiner, Omar Faridi, Mamtha Balasubramaniam, Asher Weiner; Clinical Experience with Sulcus-Implanted Baerveldt Glaucoma Tube Shunts Fully Concealed Behind the Iris in Pseudophakic Eyes. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2640.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe our clinical experience with ciliary sulcus-implanted Baerveldt glaucoma tube shunts entirely concealed behind the iris, compared to similarly implanted tubes whose openings remain fully exposed in the pupil

Methods: : A retrospective interventional non-randomized comparative chart review. Main outcome measures were postoperative tube incarceration by iris, and postoperative intraocular pressure (IOP) and number of glaucoma medications

Results: : Fifteen eyes of 15 patients were identified with sulcus-implanted fully concealed tubes (CT group) while 48 eyes of 43 patients had sulcus-implanted fully exposed tube openings (ET group) in the pupil. Follow-up period was 22.9±17.9 (mean ± SD, range, 1.0-72.0 months). Only 1 case (6.67%) of tube incarceration by iris has occurred in the CT group and none in the ET group. The blockage was treated by laser iridotomy with no recurrence. Preoperative IOP in the CT and ET groups was 27.2 ± 9.6 mmHg (range, 16-46 mmHg) and 25.2 ± 10.1 mmHg (range, 12-59 mmHg), respectively, with no significant difference between the groups. IOP was significantly reduced at final visit to 13.2 ± 4.2 mmHg (range, 6-22 mmHg, p=.0001) and 10.5 ± 4.2 mmHg (range, 4-25 mmHg, p=.0001), respectively. Final visit IOP was significantly lower in the ET group than in the CT group (p=.032). Preoperative number of glaucoma medications in the CT and ET groups was 3.87 ± 0.74 (range, 2.0-5.0) and 3.90 ± 1.04 (range, 1.0-6.0), respectively. It was significantly reduced to 1.87 ± 1.19 (range, 0.0-4.0, p=.0001) and 1.63 ± 1.38 (range, 0.0-5.0, p=.0001), respectively. There was no significant difference in the number of glaucoma medications between the groups before or after surgery. LogMAR visual acuity was similar in both groups and did not change significantly following surgery

Conclusions: : These results suggest that the risk of iris occluding sulcus-implanted Baerveldt glaucoma tube shunts entirely concealed behind the iris is small, and is treatable by laser without the need for tube repositioning. However, it appears that sulcus-implanted tubes whose openings remain fully exposed in the pupil are more effective in IOP control than tube shunts entirely concealed behind the iris

Keywords: intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×